Jian-Ming Ying (Jianming Ying, Ying Jianming)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 23

Top Topics

Tyrosine Kinase

Small Cell Lung Cancer

Epidermal Growth Factor Receptor

Chronic Myeloid Leukemia

Top Venues

Thoracic cancer

NPJ precision oncology

NPJ digital medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Yibo Zhang, Zijian Yang, Ruanqi Chen, Yanli Zhu, Li Liu, Jiyan Dong, Zicheng Zhang, Xujie Sun, Jian-Ming Ying, Dongmei Lin, Lin Yang, Meng Zhou
Histopathology images-based deep learning prediction of prognosis and therapeutic response in small cell lung cancer. NPJ digital medicine 7 (1) (2024)
Ziqiang Chen, Xiao-Bing Wang, Zelin Jin, Bosen Li, Dongxian Jiang, Yanqiu Wang, Mengping Jiang, Dandan Zhang, Pei Yuan, Yahui Zhao, Feiyue Feng, Yicheng Lin, Liping Jiang, Chenxi Wang, Weida Meng, Wenjing Ye, Jie Wang, Wenqing Qiu, Houbao Liu, Dan Huang, Yingyong Hou, Xuefei Wang, Yuchen Jiao, Jian-Ming Ying, Zhihua Liu, Yun Liu
Deep learning on tertiary lymphoid structures in hematoxylin-eosin predicts cancer prognosis and immunotherapy response. NPJ precision oncology 8 (1) (2024)
Li Sun, Wei Guo, Lei Guo, Xiaoxi Chen, Haitao Zhou, Shi Yan, Gang Zhao, Hua Bao, Xue Wu, Yang Shao, Jian-Ming Ying, Lin Lin
Molecular landscape and multi-omic measurements of heterogeneity in fetal adenocarcinoma of the lung. NPJ precision oncology 8 (1) (2024)
Yibo Zhang, Zijian Yang, Ruanqi Chen, Yanli Zhu, Li Liu, Jiyan Dong, Zicheng Zhang, Xujie Sun, Jian-Ming Ying, Dongmei Lin, Lin Yang, Meng Zhou
Histopathology images-based deep learning prediction of prognosis and therapeutic response in small cell lung cancer. NPJ digital medicine 7 (1) (2024)
Li Sun, Wei Guo, Lei Guo, Xiaoxi Chen, Haitao Zhou, Shi Yan, Gang Zhao, Hua Bao, Xue Wu, Yang Shao, Jian-Ming Ying, Lin Lin
Molecular landscape and multi-omic measurements of heterogeneity in fetal adenocarcinoma of the lung. NPJ precision oncology 8 (1) (2024)
Shuaibo Wang, Ye Li, Xujie Sun, Jiyan Dong, Li Liu, Jingbo Liu, Ruanqi Chen, Feng Li, Tiange Chen, Xiang Li, Guotong Xie, Jian-Ming Ying, Qiang Guo, Yousheng Mao, Lin Yang
Proposed novel grading system for stage I invasive lung adenocarcinoma and a comparison with the 2020 IASLC grading system. Thoracic cancer (2024)
Ziqiang Chen, Xiao-Bing Wang, Zelin Jin, Bosen Li, Dongxian Jiang, Yanqiu Wang, Mengping Jiang, Dandan Zhang, Pei Yuan, Yahui Zhao, Feiyue Feng, Yicheng Lin, Liping Jiang, Chenxi Wang, Weida Meng, Wenjing Ye, Jie Wang, Wenqing Qiu, Houbao Liu, Dan Huang, Yingyong Hou, Xuefei Wang, Yuchen Jiao, Jian-Ming Ying, Zhihua Liu, Yun Liu
Deep learning on tertiary lymphoid structures in hematoxylin-eosin predicts cancer prognosis and immunotherapy response. NPJ precision oncology 8 (1) (2024)
Shuaibo Wang, Ye Li, Xujie Sun, Jiyan Dong, Li Liu, Jingbo Liu, Ruanqi Chen, Feng Li, Tiange Chen, Xiang Li, Guotong Xie, Jian-Ming Ying, Qiang Guo, Yousheng Mao, Lin Yang
Proposed novel grading system for stage I invasive lung adenocarcinoma and a comparison with the 2020 IASLC grading system. Thoracic cancer (2024)
Shuaibo Wang, Ye Li, Xujie Sun, Jiyan Dong, Li Liu, Jingbo Liu, Ruanqi Chen, Feng Li, Tiange Chen, Xiang Li, Guotong Xie, Jian-Ming Ying, Qiang Guo, Yousheng Mao, Lin Yang
Proposed novel grading system for stage I invasive lung adenocarcinoma and a comparison with the 2020 IASLC grading system. Thoracic cancer 15 (7) (2024)
Shuaibo Wang, Ye Li, Xujie Sun, Jiyan Dong, Li Liu, Jingbo Liu, Ruanqi Chen, Feng Li, Tiange Chen, Xiang Li, Guotong Xie, Jian-Ming Ying, Qiang Guo, Yousheng Mao, Lin Yang
Proposed novel grading system for stage I invasive lung adenocarcinoma and a comparison with the 2020 IASLC grading system. Thoracic cancer 15 (7) (2024)
Shuaibo Wang, Ye Li, Xujie Sun, Jiyan Dong, Li Liu, Jingbo Liu, Ruanqi Chen, Feng Li, Tiange Chen, Xiang Li, Guotong Xie, Jian-Ming Ying, Qiang Guo, Yousheng Mao, Lin Yang
Proposed novel grading system for stage I invasive lung adenocarcinoma and a comparison with the 2020 IASLC grading system. Thoracic cancer 15 (7) (2024)
Jianqiang Cai, Weilong Zhang, Yalan Lu, Wenjie Liu, Haitao Zhou, Mei Liu, Xinyu Bi, Jianmei Liu, Jinghua Chen, Yanjiang Yin, Yiqiao Deng, Zhiwen Luo, Yi Yang, Qichen Chen, Xiao Chen, Zheng Xu, Yueyang Zhang, Chaoling Wu, Qizhao Long, Chunyuan Huang, Changjian Yan, Yan Liu, Lei Guo, Weihua Li, Pei Yuan, Yucheng Jiao, Wei Song, Xiao-Bing Wang, Zhen Huang, Jian-Ming Ying, Hong Zhao
Single-cell exome sequencing reveals polyclonal seeding and TRPS1 mutations in colon cancer metastasis. Signal transduction and targeted therapy 9 (1) (2024)
Li Sun, Wei Guo, Lei Guo, Xiaoxi Chen, Haitao Zhou, Shi Yan, Gang Zhao, Hua Bao, Xue Wu, Yang Shao, Jian-Ming Ying, Lin Lin
Molecular landscape and multi-omic measurements of heterogeneity in fetal adenocarcinoma of the lung. NPJ precision oncology 8 (1) (2024)
Guang-Yi Sun, Jing Zhang, Bing-Zhi Wang, Hao Jing, Hui Fang, Yu Tang, Yong-Wen Song, Jing Jin, Yue-Ping Liu, Yuan Tang, Shu-Nan Qi, Bo Chen, Ning-Ning Lu, Ning Li, Ye-Xiong Li, Jian-Ming Ying, Shu-Lian Wang
The prognostic value of tumour-infiltrating lymphocytes, programmed cell death protein-1 and programmed cell death ligand-1 in Stage I-III triple-negative breast cancer. British journal of cancer (2023)
Xinan Sheng, Lin Wang, Zhisong He, Yanxia Shi, Hong Luo, Weiqing Han, Xin Yao, Benkang Shi, Zhenhua Liu, Changlu Hu, Ziling Liu, Hong-Qian Guo, Guohua Yu, Zhigang Ji, Jian-Ming Ying, Yun Ling, Shiying Yu, Yi Hu, Jianming Guo, Jianmin Fang, Aiping Zhou, Jun Guo
Efficacy and Safety of Disitamab Vedotin in Patients With Human Epidermal Growth Factor Receptor 2-Positive Locally Advanced or Metastatic Urothelial Carcinoma: A Combined Analysis of Two Phase II Clinical Trials. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Shou-Zheng Wang, Tongji Xie, Yan Li, Lei Guo, Jian-Ming Ying, Yan Wang, Xuezhi Hao, Xingyuan Wang, Junling Li, Puyuan Xing
Low TP53 variant allele frequency as a biomarker for anti-programmed death (ligand) 1 monotherapy in lung adenocarcinoma. Cancer (2023)
Yan Li, Ziyi Xu, Shou-Zheng Wang, Yi-Xiang Zhu, Di Ma, Yuxin Mu, Jian-Ming Ying, Jun-Ling Li, Pu-Yuan Xing
Disease monitoring of epidermal growth factor receptor (EGFR)-mutated non-small-cell lung cancer patients treated with tyrosine kinase inhibitors via EGFR status in circulating tumor DNA. Thoracic cancer 13 (15) (2022)
Shuhang Wang, Pei Yuan, Beibei Mao, Ning Li, Jian-Ming Ying, Xiuli Tao, Wei Tang, Lei Zhang, Xiao Geng, Fan Zhang, Qi Xue, Lijia Wu, Henghui Zhang, Shugeng Gao, Jie He
Genomic features and tumor immune microenvironment alteration in NSCLC treated with neoadjuvant PD-1 blockade. NPJ precision oncology 6 (1) (2022)
Weihua Li, Lei Guo, Wanxiangfu Tang, Yutong Ma, Xiaonan Wang, Yang Shao, Hong Zhao, Jian-Ming Ying
Identification of DNA methylation biomarkers for risk of liver metastasis in early-stage colorectal cancer. Clinical epigenetics 13 (1) (2021)
Yan Li, Fanshuang Zhang, Pei Yuan, Lei Guo, Jian-Ming Ying, Jie He
High MAF of EGFR mutations and high ratio of T790M sensitizing mutations in ctDNA predict better third-generation TKI outcomes. Thoracic cancer 11 (6) (2020)
Yun Ling, Ning Li, Lin Li, Changyuan Guo, Jiacong Wei, Pei Yuan, Fengwei Tan, Xiuli Tao, Shuhang Wang, Zhijie Wang, Ning Wu, Jie Wang, Jian-Ming Ying, Shugeng Gao, Jie He
Different pathologic responses to neoadjuvant anti-PD-1 in primary squamous lung cancer and regional lymph nodes. NPJ precision oncology 4 (1) (2020)
Xuemin Xue, Wenting Huang, Tian Qiu, Lei Guo, Jian-Ming Ying, Ning Lv
DLBCL with amplification of JAK2/PD-L2 exhibits PMBCL-like CNA pattern and worse clinical outcome resembling those with MYD88 L265P mutation. BMC cancer 20 (1) (2020)
Wenting Huang, Xuemin Xue, Ling Shan, Tian Qiu, Lei Guo, Jian-Ming Ying, Ning Lu
Clinical significance of PCDH10 promoter methylation in diffuse large B-cell lymphoma. BMC cancer 17 (1) (2017)